Suven Pharmaceuticals Limited (SUVENPHAR) — Net Asset Quality Index
Suven Pharmaceuticals Limited (SUVENPHAR) has a Net Asset Quality Index of 60.7% as of March 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs30.32 Billion minus total liabilities of Rs11.91 Billion yields net assets of Rs18.41 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Suven Pharmaceuticals Limited (SUVENPHAR) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Suven Pharmaceuticals Limited Net Asset Quality Index Over Time (2019–2025)
This chart shows how Suven Pharmaceuticals Limited's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2025, the index stands at 60.7%, representing net assets of Rs18.41 Billion against total assets of Rs30.32 Billion INR. See SUVENPHAR current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Suven Pharmaceuticals Limited (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for Suven Pharmaceuticals Limited from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see SUVENPHAR company net worth.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 60.7% | Rs18.41 Billion | Rs30.32 Billion | Rs11.91 Billion | ▼ -30.3 pp |
| 2024 | 91.0% | Rs20.51 Billion | Rs22.54 Billion | Rs2.03 Billion | ▲ +2.7 pp |
| 2023 | 88.3% | Rs17.35 Billion | Rs19.66 Billion | Rs2.31 Billion | ▲ +4.8 pp |
| 2022 | 83.5% | Rs15.27 Billion | Rs18.30 Billion | Rs3.02 Billion | ▲ +3.4 pp |
| 2021 | 80.1% | Rs11.81 Billion | Rs14.74 Billion | Rs2.94 Billion | ▲ +8.1 pp |
| 2020 | 72.0% | Rs8.45 Billion | Rs11.73 Billion | Rs3.28 Billion | ▼ -3.4 pp |
| 2019 | 75.4% | Rs5.90 Billion | Rs7.83 Billion | Rs1.93 Billion | — |